Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | BCL2 | P10415 | 1/20 | 0.50 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.50 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30148126 | 1.00 | HTR2A (0.63) | HTR2ATDP1BCL2BCL2L1CALM1 | |
| SCHEMBL24244161 | 0.84 | TDP1 (0.68) | HTR2ATDP1TSHRKEAP1HPGD | |
| SCHEMBL26987950 | 0.84 | HTR2A (0.46) | HTR2ATDP1BCL2BCL2L1TSHR | |
| SCHEMBL972711 | 0.83 | CALM1 (0.69) | HTR2ABCL2BCL2L1CALM1ALOX5 | |
| SCHEMBL29534868 | 0.83 | TDP1 (0.55) | HTR2ATDP1TSHRHIF1A | |
| SCHEMBL31203 | 0.83 | TDP1 (0.55) | HTR2ATDP1TSHRHIF1A | |
| SCHEMBL16499740 | 0.82 | TDP1 (0.65) | HTR2ATDP1TSHRHPGDALOX15 | |
| SCHEMBL1773099 | 0.81 | HTR2A (0.56) | HTR2ATDP1BCL2BCL2L1CALM1 | |
| SCHEMBL2996327 | 0.81 | HTR2A (0.68) | HTR2ATDP1BCL2BCL2L1CALM1 | |
| SCHEMBL8873128 | 0.81 | HTR2A (0.52) | HTR2ATDP1BCL2BCL2L1CALM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4140974-B1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | VERSITECH LTD (CN) | 2025-05-14 | — | — | EP | disclosed |
| US-12098126-B2 | Methods of iron catalyzed C-H bond amination | VERSITECH LIMITED (CN) | 2024-09-24 | — | — | US | disclosed |
| US-20230121302-A1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | VERSITECH LIMITED (CN) | 2023-04-20 | — | — | US | disclosed |
| EP-4140974-A1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | The University of Hong Kong (HK) | 2023-03-01 | — | — | EP | disclosed |
| CN-115710210-A | Iron catalyzed amination of C-H bonds | 港大科桥有限公司 | 2023-02-24 | — | — | CN | disclosed |
| EP-3193881-B1 | HISTONE DEMETHYLASE INHIBITORS | CELGENE QUANTICEL RES INC (US) | 2022-02-09 | — | — | EP | disclosed |
| US-5604242-A | ALKOXY- AND CARBOXY-SUBSTITUTED PIPERIDINES FOR SUPPRESSING UPTAKE OF GAMMA-AMINOBUTYRIC ACID, ANALGESICS, ANXIOLYTIC OR ANTIEPILEPTIC AGENTS | NOVO NORDISK A/S (DK) | 1997-02-18 | — | — | US | disclosed |
| CN-1128989-A | N-substituted azaheterocylic carboxylic acid and esters thereof | NOVO NORDISK AS (DK) | 1996-08-14 | — | — | CN | disclosed |
| EP-0705248-A1 | N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS THEREOF | NOVO NORDISK A/S (DK) | 1996-04-10 | — | — | EP | disclosed |
| WO-1995000486-A1 | N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS THEREOF | NOVO NORDISK A/S (DK) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12098126-B2 | Methods of iron catalyzed C-H bond amination | FTH1, FECH, HCCS | HTR2A 1233/4885TDP1 4855/4885BCL2 4057/4885 |
| US-20230121302-A1 | METHODS OF IRON CATALYZED C-H BOND AMINATION | FTH1, FECH, HCCS | HTR2A 1233/4885TDP1 4855/4885BCL2 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.